4.0 Letter

Association between the FCGR3A V158F polymorphism and the clinical response to infliximab in rheumatoid arthritis and spondyloarthritis patients

Related references

Note: Only part of the references are listed.
Article Rheumatology

Improvement in Hemoglobin Levels in Patients With Ankylosing Spondylitis Treated With Infliximab

Juergen Braun et al.

ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)

Article Biochemistry & Molecular Biology

Differences in binding and effector functions between classes of TNF antagonists

Taruna Arora et al.

CYTOKINE (2009)

Article Biotechnology & Applied Microbiology

Polymorphism in IgG Fc receptor gene FCGR3A and response to infliximab in Crohn's disease: a subanalysis of the ACCENT I study

Edouard I. Louis et al.

PHARMACOGENETICS AND GENOMICS (2006)